Wanda Health, the intelligent platform for Remote Patient Monitoring and Virtual Care, has successfully closed a fundraising of £1 million. The funding was led and syndicated by EMV Capital.
The proceeds from the fundraising will provide Wanda Health with the capital to execute its growth strategy, which includes:
Wanda Health recently announced a high-profile partnership with COPD Foundation providing it with access to world-leading clinical experts, clinical guideline content, as well as joint marketing and advertising opportunities. This collaboration enhances Wanda Health's ability to refine its disease monitoring platform, particularly for conditions like COPD, which affects over 400 million people globally.
Wanda Health, a spinout from UCLA, is a leading remote patient monitoring and virtual care platform operating in the UK and US. Delivered as a Software-as-a-Service (SaaS) solution, it is cloud-hosted with proprietary machine learning (ML) and artificial intelligence (AI) capabilities. Wanda Health empowers healthcare providers and payers by enabling early detection of health exacerbations across acute, chronic, and specialty disease spaces, improving patient outcomes and reducing costs.
Wanda Health operates in a high-growth sector, with RPM projected to grow to $175 billion by 2027, Remote Therapeutic Management estimated to reach $17 billion by 2030, and Chronic Care Management predicted to reach $32 billion by 2033. With a robust pipeline of growth opportunities, Wanda Health is well-positioned to lead the way in RPM and Virtual Care.